About Han Ul Medizin (India) LLP
Data last updated:
Han Ul Medizin (India) LLP is a limited liability partnership (LLP) based in Pune, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 01 April 2013 and has been in existence for over 13 years.
The LLP is registered with the Registrar of Companies (ROC), Pune, under LLPIN AAB-4335. Its GSTIN is 27AAHFH3014J1ZJ (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Vivek Gopal Bele and Kedar Shashikant Joshi.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Fl – 504 Wing – E S – 133/B Laxminarayan Tower Fp – 587/3 Nr.Bhagyashri Soc Parvati, Pune, Maharashtra, India – 411030.
As per the financials filed for FY 2020, the LLP reported a revenue of ₹17.75 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹5.55 Lakh (net margin 31.2%) and EBITDA of ₹16.84 Lakh (EBITDA margin 94.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 12% over five years.
For more details, the LLP can be reached via its website hanulmedizin.com.
Company details
Contact details
Han Ul Medizin (India) LLP's registered office is in Pune, Maharashtra. Its website is hanulmedizin.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFl – 504 Wing – E S – 133/B Laxminarayan Tower Fp – 587/3 Nr.Bhagyashri Soc Parvati, Pune, Maharashtra, India – 411030
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Han Ul Medizin (India) LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Han Ul Medizin (India) LLP
FY 2025 filings availableHan Ul Medizin (India) LLP reported revenue of ₹17.75 Lakh (down 23% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 23% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | ₹17.75 Lakh | ||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹5.55 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 31.2% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Han Ul Medizin (India) LLP, buy the company report.
Designated partners of Han Ul Medizin (India) LLP
Han Ul Medizin (India) has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Gopal Bele | Designated Partner | 01 Apr 2013 | 13 Years 7 Months | Current |
| Kedar Shashikant Joshi | Designated Partner | 01 Apr 2013 | 13 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Han Ul Medizin (India) LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Han Ul Medizin (India) LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Han Ul Medizin (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHFH3014J1ZJ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Han Ul Medizin (India) LLP, buy the company report.
Recent activity
Han Ul Medizin (India) LLP has 2 designated partner changes on record since 2013: 2 appointments. The latest: Kedar Shashikant Joshi was appointed as Designated Partner on 01 Apr 2013.
Frequently asked questions
Han Ul Medizin (India) is an active limited liability partnership based in Pune, Maharashtra, India. The LLP works in pharma contract r and d, within the pharma industry. It was incorporated on 01 April 2013 (13+ years old) and is registered under LLPIN AAB-4335.
Han Ul Medizin (India) has 2 current designated partners:
- Vivek Gopal Bele - Designated Partner
- Kedar Shashikant Joshi - Designated Partner
The latest financial statements of Han Ul Medizin (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Han Ul Medizin (India) is 27AAHFH3014J1ZJ, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Han Ul Medizin (India) is AAB-4335. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Han Ul Medizin (India) was incorporated on 01 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Pune.
Kedar Shashikant Joshi was appointed as Designated Partner on 01 Apr 2013. Vivek Gopal Bele was appointed as Designated Partner on 01 Apr 2013.
Han Ul Medizin (India) can be reached through the website hanulmedizin.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Han Ul Medizin (India) is at Fl – 504 Wing – E S – 133B Laxminarayan Tower Fp – 5873 Nr.Bhagyashri Soc Parvati, Pune, Maharashtra, India – 411030.
Han Ul Medizin (India) operates in the pharma industry, in the pharma contract r and d segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
